Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation.

Purpose: To evaluate the efficacy of cyclosporine 0.05% in alleviating dry-eye signs and improving visual quality after multifocal intraocular lens (IOL) implantation.

Setting: Private practice and university medical center, New York, New York, USA.

Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.

Purpose: To compare the efficacy of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.

Methods: Patients with dry eye (N = 30) seen in a university-affiliated private practice were randomized to 1 of 3 treatments: cyclosporine 0.05% ophthalmic emulsion (RESTASIS) twice daily, lower-lid punctal plugs (PARASOL), or a plugs-cyclosporine combination.

Dry eye symptoms following cataract surgery.

This randomized, controlled clinical study demonstrates the development of dry eye-type symptoms after routine cataract extraction, and shows that topical cyclosporine ophthalmic emulsion can reduce the occurrence of these symptoms after cataract surgery. Based on these results, a regimen of pre- and postoperative topical cyclosporine should be considered for cataract patients who have dry eyes or who are at risk of developing dry eye. This paper presents the study methodology and results, and discusses implications for care of cataract patients so as to improve the quality of vision after surgery and to maximize patient satisfaction with the procedure.

Comparative analysis of prednisolone acetate suspensions.

Purpose: The aim of this study was to determine differences in particle size between three prednisolone acetate suspensions: Pred Forte, EconoPred Plus, and generic prednisolone acetate 1%.

Setting: This study employed the setting of a laboratory evaluation.

Methods: Qualitative assessment of sedimentation rate as a function of particle size was the method employed for this study.

Topical NSAIDS to control pain in clear corneal cataract extraction.

This study was conducted to assess the additive efficacy of ophthalmic topical nonsteroidal anti-inflammatory drugs (NSAIDs) with topical anesthesia in the control of pain associated with clear corneal cataract extraction. The patients who received three days of preoperative topical NSAIDs had a statistically significant decrease in their level of discomfort. We have previously shown that three days of preoperative NSAIDs can reduce postoperative inflammation after cataract surgery.